14.09.2018
- Following the completion of its $64 billion takeover of Shire, Japanese drugmaker Takeda has announced plans to restructure its US operations. In a first move, it will close its...
04.09.2018
- Ahead of its acquisition by Japan’s Takeda Pharmaceutical, Ireland-domiciled, London-listed and US-focused Shire has completed the sale of its oncology portfolio with $262 million...
11.07.2018
- On its path to acquiring Ireland-domiciled, London-listed drugmaker Shire, Japan’s Takeda Pharmaceutical has received unconditional clearance from the US Federal Trade Commission...
09.05.2018
- Takeda Pharmaceutical and Shire have finally agreed terms for a merger, ending a takeover battle that has seen the Japanese drugmaker bid five times since late March for the...
26.04.2018
- Shire has announced that it would be willing to recommend Takeda’s latest and fifth proposal to its shareholders. The revised offer, Takeda’s fifth in recent weeks, values Shire at...
24.04.2018
- Japanese drugmaker Takeda has hiked its bid for Shire, also increasing the cash part of the deal. In its latest proposal, made on Apr. 20, Takeda has offered £47 per share, valuing...
18.04.2018
- Ireland-based drugs giant Shire is selling its oncology business to France’s Servier in a deal worth $2.4 billion. The sale comes just as Japan’s Takeda Pharmaceutical was reported...
04.04.2018
- Japanese drugmaker Takeda has announced that it is considering buying Ireland-domiciled drugmaker Shire, although it stressed that the offer was “at a preliminary and exploratory...
